ArticleFrontiers in oncology2019
Latin American Study of Hereditary Breast and Ovarian Cancer
Open access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.
- Pathogenic variants inJournal of medicine and life · 2025Pooled it
- NGS in Lung, Breast, and Unknown Primary Cancer in Colombia: A Multidisciplinary Consensus on Challenges and Opportunities.JCO global oncology · 2021Guideline
- Summary ofGenes · 2020Pooled it
- First report of MUTYH-associated polyposis with c.1353_1355del and c.452A>G mutations in Tolima Grande region from Colombia: a case report.Frontiers in oncology · 2026Article
- Mono-allelic MUTYH mutation as the likely inherited etiology of hereditary breast cancer in a patient from a multi-cancer family- report of a family and literature review.BMC medical genomics · 2025Review
- Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review.ACS omega · 2025Review
- Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohort.European journal of human genetics : EJHG · 2025Article
- Cancer genomics and bioinformatics in Latin American countries: applications, challenges, and perspectives.Frontiers in oncology · 2025Review
- Risk Factors for Ovarian Cancer in South America: A Literature Review.Journal of personalized medicine · 2024Review
- Prevalence of germline variants in Brazilian pancreatic carcinoma patients.Scientific reports · 2024Article
- Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria.NPJ precision oncology · 2024Article
- Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies.Breast cancer research and treatment · 2024Article
- Article
- Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer?Cancers · 2024Article
- Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.Human genomics · 2023Article
- Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico.Frontiers in genetics · 2023Article
- Current landscape and future directions of synthetic biology in South America.Frontiers in bioengineering and biotechnology · 2023Review
- Article
- Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study.JCO global oncology · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors at 17 institutions in 6 countries.
Javier OliverMedical Oncology Service, Hospitales Universitarios Regional y Virgen de la Victoria, Institute of Biomedical Research in Malaga, CIMES, University of Málaga, Málaga, Spain.
Rosalía Quezada UrbanLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Claudia Alejandra Franco CortésLaboratorio de Secuenciación, Instituto de Medicina Traslacional e Ingeniería Biomédica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Clara Estela Díaz VelásquezLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Ana Lorena Montealegre PaezInstituto de Nutrición, Genética y Metabolismo, Facultad de Medicina, Universidad El Bosque, Bogota, Colombia.
Rafael Adrián Pacheco-OrozcoInstituto de Nutrición, Genética y Metabolismo, Facultad de Medicina, Universidad El Bosque, Bogota, Colombia.
Carlos Castro RojasInstituto de Nutrición, Genética y Metabolismo, Facultad de Medicina, Universidad El Bosque, Bogota, Colombia.
Reggie García-RoblesInstituto de Nutrición, Genética y Metabolismo, Facultad de Medicina, Universidad El Bosque, Bogota, Colombia.
Juan Javier López RiveraGrupo INPAC, Organización Keralty, Departamento de Genética, Clínica Universitaria Colombia, Bogotá, Colombia.
Sandra Gaitán ChaparroGrupo INPAC, Organización Keralty, Facultad de Medicina, Fundación Universitaria Sanitas, Bogotá, Colombia.
Ana Milena GómezServicio de Genética, Hospital Universitario San Ignacio, Bogotá, Colombia.
Fernando Suarez ObandoServicio de Genética, Hospital Universitario San Ignacio, Bogotá, Colombia.
Gustavo GiraldoClínica Universitaria Bolivariana, Pontificia Universidad Bolivariana, Medellín, Colombia.
Maria Isabel MayaClínica Universitaria Bolivariana, Pontificia Universidad Bolivariana, Medellín, Colombia.
Paula Hurtado-VillaDepartamento Ciencias Básicas de Salud, Facultad de Ciencias de la Salud, Pontificia Universidad Javeriana Cali, Cali, Colombia.
Ana Isabel SanchezCentro Médico Imbanaco, Cali, Colombia.
Norma SerranoFundación Cardiovascular de Colombia, Centro de Investigaciones, Floridablanca, Colombia.
Ana Isabel Orduz GalvisFundación Cardiovascular de Colombia, Centro de Investigaciones, Floridablanca, Colombia.
Sandra AruachanDepartamento de Investigación y Estudios Clínicos, IMAT - Oncomédica S.A., Montería, Colombia.
Johanna Nuñez CastilloDepartamento de Investigación y Estudios Clínicos, IMAT - Oncomédica S.A., Montería, Colombia.
Cecilia FrechaInstituto de Medicina Traslacional e Ingeniería Biomédica, CONICET-Instituto Universitario del Hospital Italiano-Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Cecilia RiggiServicio de Ginecología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Federico JaukLaboratorio de Secuenciación, Instituto de Medicina Traslacional e Ingeniería Biomédica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Eva María Gómez GarcíaCentro Oncológico Estatal ISSEMyM, Toluca de Lerdo, Mexico.
Claudia Lorena CarranzaINVEGEM, Guatemala, Guatemala.
Vanessa ZamoraINVEGEM, Guatemala, Guatemala.
Gabriela Torres MejíaInstituto Nacional de Salud Pública, Cuernavaca, Mexico.
Isabelle RomieuInstituto Nacional de Salud Pública, Cuernavaca, Mexico.
Carlos Arturo CastañedaDepartamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Miluska CastilloDepartamento de Investigación, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Rina GitlerFundación Alma, Ciudad de México, Mexico.
Adriana AntonianoFundación Alma, Ciudad de México, Mexico.
Ernesto Rojas JiménezLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Luis Enrique Romero CruzLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Fernando Vallejo LecuonaLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Iván Delgado EncisoInstituto Estatal de Cancerología de Colima, Colima, Mexico.
Abril Bernardette Martínez RizoLaboratorio de Investigación Biomédica, Unidad Académica de Medicina, Universidad Autónoma de Nayarit, Tepic, Mexico.
Alejandro Flores CarranzaInstituto Mexicano del Seguro Social, Ciudad de México, Mexico.
Verónica Benites GodinezInstituto Mexicano del Seguro Social, Ciudad de México, Mexico.
Claudia Fabiola Méndez CataláLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Luis Alonso HerreraUnidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas-Instituto Nacional de Cancerología, Ciudad de México, Mexico.
Yolanda Irasema ChirinoUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, UNAM, Tlalnepantla de Baz, Mexico.
Luis Ignacio TerrazasLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Sandra PerdomoInstituto de Nutrición, Genética y Metabolismo, Facultad de Medicina, Universidad El Bosque, Bogota, Colombia.
Felipe Vaca PaniaguaLaboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla de Baz, Mexico.
Autonomous University of Tlaxcala · MXUniversidad El Bosque · COHospital Italiano de Buenos Aires · ARFundación Cardiovascular de Colombia · COFundación Universitaria Sanitas · COInstituto Nacional de Cancerología · MXInstituto Nacional de Enfermedades Neoplásicas · PEInstituto Nacional de Salud Pública · MXMexican Social Security Institute · MXPontificia Universidad Javeriana · COUniversidad Pontificia Bolivariana · COCaucaseco Scientific Research Center · COHospital Universitario San Ignacio · COInstituto de Salud del Estado de México · MXUniversidad Autónoma de Nayarit · MXUniversidad de Colima · MXUniversidad de Málaga · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast cancer susceptibilitygermline pathogenic variantsHBOCLatin Americamassively parallel sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.